Skip to content
drillr.ai
Sign up

LGVN

Longeveron Inc.

NASDAQ · Healthcare · Biotechnology · US

$6.81
+3.50%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue1.2M1.2M2.4M709.0K1.2M
Cost of Revenue359.0K396.0K508.0K488.0K725.0K
Gross Profit828.0K803.0K1.9M221.0K497.0K
Operating Expenses
R&D Expense12.1M12.0M8.1M9.1M9.4M
SG&A Expense12.4M12.0M10.3M12.2M9.2M
General & Admin Expense12.4M12.0M9.5M12.2M8.1M
Selling & Marketing Expense——800.0K—1.1M
Other Expenses—————
Total Operating Expenses24.5M24.1M18.4M21.3M18.5M
Cost and Expenses24.8M24.5M18.9M21.7M19.3M
Operating Income (EBIT)(23.7M)(23.3M)(16.5M)(21.0M)(18.0M)
Non-Operating
Interest Income—————
Interest Expense—————
Net Interest Income—————
Other Non-Op Income/Expense181.0K583.0K549.0K(384.0K)(792.0K)
Non-Operating Income (excl Interest)15.0K(583.0K)(549.0K)384.0K792.0K
EBT (Pre-Tax Income)(23.5M)(22.7M)(16.0M)(21.4M)(18.8M)
Income Tax Expense—————
Bottom Line
Net Income(23.5M)(22.7M)(16.0M)(21.4M)(18.8M)
Earnings from Cont. Ops(23.5M)(22.7M)(16.0M)(21.4M)(18.8M)
Earnings from Discont. Ops—————
Bottom Line Net Income(23.5M)(22.7M)(16.0M)(22.2M)(18.8M)
Per Share
Basic EPS($10.10)($12.90)($10.70)($102.20)($90.00)
Diluted EPS($10.10)($12.90)($10.70)($102.20)($90.00)
Revenue Per Share$0.38$0.68$1.61$3.26$5.83
Shares
Basic Shares Outstanding3.1M1.8M1.5M217349209690
Diluted Shares Outstanding3.1M1.8M1.5M217349209690
Profitability Metrics
EBITDA(22.9M)(21.5M)(15.0M)(20.5M)(17.9M)
D&A794.0K1.2M958.0K946.0K893.0K
EBIT(23.7M)(22.7M)(16.0M)(21.4M)(18.8M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026